• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性烟酰胺腺嘌呤二核苷酸磷酸氧化酶激活增强脑缺血再灌注后缓激肽引起的脑血管通透性反应。

Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion.

机构信息

BHF Centre of Research Excellence, Cardiovascular Division, King's College London, London SE1 9NH, UK.

出版信息

Free Radic Biol Med. 2011 Feb 15;50(4):518-24. doi: 10.1016/j.freeradbiomed.2010.12.010. Epub 2010 Dec 16.

DOI:10.1016/j.freeradbiomed.2010.12.010
PMID:21167936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3038265/
Abstract

Free radical generation is a key event in cerebral reperfusion injury. Bradykinin (Bk) and interleukin-1β (IL-1β) have both been implicated in edema formation after stroke, although acute Bk application itself results in only a modest permeability increase. We have investigated the molecular mechanism by assessing the permeability of single pial venules in a stroke model. Increased permeability on reperfusion was dependent on the duration of ischemia and was prevented by applying the B(2) receptor antagonist HOE 140. Postreperfusion permeability increases were mimicked by applying Bk (5μM) for 10 min and blocked by coapplying the IL-1 receptor antagonist with Bk. Furthermore, 10 min pretreatment with IL-1β resulted in a 3 orders of magnitude leftward shift of the acutely applied Bk concentration-response curve. The left shift was abolished by scavenging free radicals with superoxide dismutase and catalase. Apocynin coapplied with IL-1β completely blocked the potentiation, implying that NADPH oxidase assembly is the immediate target of IL-1β. In conclusion, this is first demonstration that bradykinin, released during cerebral ischemia, leads to IL-1β release, which in turn activates NADPH oxidase leading to blood-brain barrier breakdown.

摘要

自由基的产生是脑再灌注损伤的关键事件。缓激肽(Bk)和白细胞介素-1β(IL-1β)都与中风后水肿的形成有关,尽管急性 Bk 应用本身只会导致轻微的通透性增加。我们通过评估中风模型中单脑膜小静脉的通透性来研究分子机制。再灌注时通透性的增加取决于缺血的持续时间,应用 B(2)受体拮抗剂 HOE 140 可预防。Bk(5μM)作用 10 分钟可模拟再灌注后的通透性增加,并且与 Bk 共同应用 IL-1 受体拮抗剂可阻断这种增加。此外,用 IL-1β预处理 10 分钟会导致急性应用 Bk 的浓度-反应曲线向左移动 3 个数量级。用超氧化物歧化酶和过氧化氢酶清除自由基可消除这种左移。阿朴肉桂酸与 IL-1β 共同应用可完全阻断这种增强作用,这表明 NADPH 氧化酶的组装是 IL-1β 的直接靶标。总之,这首次证明了缓激肽在脑缺血期间释放,导致白细胞介素-1β 的释放,而白细胞介素-1β 又激活 NADPH 氧化酶导致血脑屏障破裂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/555453738662/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/ca2724ecc2e3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/c4406606204c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/36edebbd049a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/a68d466eb800/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/555453738662/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/ca2724ecc2e3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/c4406606204c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/36edebbd049a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/a68d466eb800/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8993/3038265/555453738662/gr5.jpg

相似文献

1
Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion.急性烟酰胺腺嘌呤二核苷酸磷酸氧化酶激活增强脑缺血再灌注后缓激肽引起的脑血管通透性反应。
Free Radic Biol Med. 2011 Feb 15;50(4):518-24. doi: 10.1016/j.freeradbiomed.2010.12.010. Epub 2010 Dec 16.
2
Redox Regulation of Microvascular Permeability: IL-1β Potentiation of Bradykinin-Induced Permeability Is Prevented by Simvastatin.微血管通透性的氧化还原调节:辛伐他汀可预防白细胞介素-1β增强缓激肽诱导的通透性
Antioxidants (Basel). 2020 Dec 14;9(12):1269. doi: 10.3390/antiox9121269.
3
Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain.缺血再灌注海马损伤中 NADPH 氧化酶抑制剂夹竹桃麻素的作用。
Biomed Pharmacother. 2018 Jan;97:458-472. doi: 10.1016/j.biopha.2017.10.123. Epub 2017 Nov 6.
4
Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation.NADPH氧化酶在晚期糖基化终末产物受体激活所致视网膜微血管通透性增加中的作用
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1319-28. doi: 10.1167/iovs.08-2730. Epub 2008 Nov 7.
5
Selective impairment of response to acetylcholine after ischemia/reperfusion in mice.
Stroke. 1997 Feb;28(2):448-51; discussion 451-2. doi: 10.1161/01.str.28.2.448.
6
Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat.缓激肽对麻醉大鼠脑微血管通透性的急性影响。
J Physiol. 2000 Oct 1;528 Pt 1(Pt 1):177-87. doi: 10.1111/j.1469-7793.2000.00177.x.
7
NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.骨髓来源细胞中的NADPH氧化酶介导肺缺血再灌注损伤。
Am J Respir Cell Mol Biol. 2009 Mar;40(3):375-81. doi: 10.1165/rcmb.2008-0300OC. Epub 2008 Sep 11.
8
Bradykinin inhibits oxidative stress-induced cardiomyocytes senescence via regulating redox state.缓激肽通过调节氧化还原状态抑制氧化应激诱导的心肌细胞衰老。
PLoS One. 2013 Oct 25;8(10):e77034. doi: 10.1371/journal.pone.0077034. eCollection 2013.
9
NADPH oxidase mediates the expression of MMP-9 in cerebral tissue after ischemia-reperfusion damage.烟酰胺腺嘌呤二核苷酸磷酸氧化酶介导缺血再灌注损伤后脑组织中基质金属蛋白酶-9的表达。
Neurol Res. 2014 Feb;36(2):118-25. doi: 10.1179/1743132813Y.0000000266. Epub 2013 Dec 6.
10
Polyethylene glycol superoxide dismutase and catalase attenuate increased blood-brain barrier permeability after ischemia in piglets.聚乙二醇超氧化物歧化酶和过氧化氢酶可减轻仔猪缺血后血脑屏障通透性的增加。
Stroke. 1992 May;23(5):755-62. doi: 10.1161/01.str.23.5.755.

引用本文的文献

1
Normobaric Hyperoxia Therapy in Treating Stroke.常压高氧疗法治疗中风
Clin Interv Aging. 2025 Jul 2;20:969-981. doi: 10.2147/CIA.S521584. eCollection 2025.
2
Redox Regulation of Microvascular Permeability: IL-1β Potentiation of Bradykinin-Induced Permeability Is Prevented by Simvastatin.微血管通透性的氧化还原调节:辛伐他汀可预防白细胞介素-1β增强缓激肽诱导的通透性
Antioxidants (Basel). 2020 Dec 14;9(12):1269. doi: 10.3390/antiox9121269.
3
Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

本文引用的文献

1
Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells.促炎细胞因子通过线粒体和NADPH氧化酶增加培养的视网膜色素上皮(RPE)细胞中的活性氧。
Exp Eye Res. 2007 Oct;85(4):462-72. doi: 10.1016/j.exer.2007.06.013. Epub 2007 Jun 27.
2
Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia.缓激肽的神经保护作用源于其对活化小胶质细胞释放促炎细胞因子的抑制。
J Neurochem. 2007 Apr;101(2):397-410. doi: 10.1111/j.1471-4159.2006.04339.x.
3
Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling.
激肽释放酶-激肽系统在神经紊乱中的意义:探寻潜在的生物标志物和机制。
Prog Neurobiol. 2018 Jun-Aug;165-167:26-50. doi: 10.1016/j.pneurobio.2018.01.003. Epub 2018 Jan 31.
4
NOX Activation by Subunit Interaction and Underlying Mechanisms in Disease.亚基相互作用介导的NADPH氧化酶激活及其在疾病中的潜在机制
Front Cell Neurosci. 2017 Jan 10;10:301. doi: 10.3389/fncel.2016.00301. eCollection 2016.
5
Reactive oxygen species facilitate the EDH response in arterioles by potentiating intracellular endothelial Ca(2+) release.活性氧通过增强细胞内内皮细胞钙离子释放来促进小动脉的内皮依赖性超极化反应。
Free Radic Biol Med. 2016 Aug;97:274-284. doi: 10.1016/j.freeradbiomed.2016.06.010. Epub 2016 Jun 16.
6
Efficacy of prophylactic flavan-3-ol in permanent focal ischemia in 12-mo-old mice.预防性黄烷-3-醇对12月龄小鼠永久性局灶性缺血的疗效。
Am J Physiol Heart Circ Physiol. 2015 Mar 15;308(6):H583-91. doi: 10.1152/ajpheart.00239.2014. Epub 2015 Jan 9.
7
Temporal and spatial distribution of Nrf2 in rat brain following stroke: quantification of nuclear to cytoplasmic Nrf2 content using a novel immunohistochemical technique.脑缺血后大鼠脑中 Nrf2 的时空分布:一种新的免疫组织化学技术检测核内 Nrf2 含量。
J Physiol. 2013 Jul 15;591(14):3525-38. doi: 10.1113/jphysiol.2013.257964. Epub 2013 May 20.
8
Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system.局部照射后心脏炎症受激肽释放酶-激肽系统影响。
Cancer Res. 2012 Oct 1;72(19):4984-92. doi: 10.1158/0008-5472.CAN-12-1831. Epub 2012 Aug 3.
9
NADPH oxidase in stroke and cerebrovascular disease.中风和脑血管疾病中的NADPH氧化酶
Neurol Res. 2012 May;34(4):338-45. doi: 10.1179/1743132812Y.0000000021.
10
Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.靶向小胶质细胞介导的神经毒性:NOX2 抑制剂的潜力。
Cell Mol Life Sci. 2012 Jul;69(14):2409-27. doi: 10.1007/s00018-012-1015-4. Epub 2012 May 13.
通过氯离子通道3产生的内皮细胞超氧化物通量介导细胞内信号传导。
Mol Biol Cell. 2007 Jun;18(6):2002-12. doi: 10.1091/mbc.e06-09-0830. Epub 2007 Mar 14.
4
IL-1beta-induced transcriptional up-regulation of bradykinin B1 and B2 receptors in murine airways.白细胞介素-1β诱导小鼠气道中缓激肽B1和B2受体的转录上调。
Am J Respir Cell Mol Biol. 2007 Jun;36(6):697-705. doi: 10.1165/rcmb.2005-0369OC. Epub 2007 Jan 25.
5
Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.在大鼠短暂性局灶性脑缺血后,分泌型磷脂酶A2 IIA被肿瘤坏死因子-α和白细胞介素-1α/β上调。
Brain Res. 2007 Feb 23;1134(1):199-205. doi: 10.1016/j.brainres.2006.11.080. Epub 2007 Jan 3.
6
The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition.髓过氧化物酶催化的芹菜素氧化:对NADPH氧化酶抑制作用的提议。
Arch Biochem Biophys. 2007 Jan 15;457(2):134-41. doi: 10.1016/j.abb.2006.11.010. Epub 2006 Nov 18.
7
Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury.缓激肽B2受体的早期激活会加重缺血/再灌注损伤中的活性氧生成和肾损伤。
Free Radic Biol Med. 2006 Oct 15;41(8):1304-14. doi: 10.1016/j.freeradbiomed.2006.07.011. Epub 2006 Jul 15.
8
Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats.大鼠局灶性脑缺血后缓激肽B2受体抑制的治疗窗
Neurochem Int. 2006 Oct;49(5):442-7. doi: 10.1016/j.neuint.2006.02.010. Epub 2006 Apr 19.
9
Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor.在缺乏缓激肽B2受体的小鼠中,缺血后脑部损伤会加剧。
Hypertension. 2006 Apr;47(4):752-61. doi: 10.1161/01.HYP.0000214867.35632.0e. Epub 2006 Mar 13.
10
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients.白细胞介素-1受体拮抗剂用于急性中风患者的随机II期研究。
J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1366-72. doi: 10.1136/jnnp.2004.054882.